thiazoles has been researched along with activins in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, S; Canaff, L; De Guise, C; Devost, D; Hendy, GN; Lacerte, A; Lebrun, JJ; Lee, EH; Reynaud, R | 1 |
| Funaba, M; Ikeda, T; Murakami, M; Nakaya, K; Sugino, H; Tsuchida, K | 1 |
| Gámez, B; Mishina, Y; Rosa, JL; Sánchez-de-Diego, C; Valer, JA; Ventura, F | 1 |
3 other study(ies) available for thiazoles and activins
| Article | Year |
|---|---|
Activin inhibits pituitary prolactin expression and cell growth through Smads, Pit-1 and menin.
Topics: Activins; Animals; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; CHO Cells; Coloring Agents; Cricetinae; DNA-Binding Proteins; Down-Regulation; Gene Expression Regulation; Genes, Reporter; Humans; Mutagenesis; Oligonucleotides, Antisense; Pituitary Gland; Prolactin; Promoter Regions, Genetic; Protein Structure, Tertiary; Proto-Oncogene Proteins; Rats; RNA, Messenger; RNA, Small Interfering; Smad Proteins; Tetrazolium Salts; Thiazoles; Time Factors; Trans-Activators; Transcription Factor Pit-1; Transcription Factors; Transcription, Genetic; Transfection | 2004 |
Requirement of Smad3 for mast cell growth.
Topics: Activins; Animals; Bone Marrow Cells; Cell Cycle; Cell Division; Cells, Cultured; Culture Media, Conditioned; Gene Expression Regulation; Inhibin-beta Subunits; Mast Cells; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-kit; Receptors, IgE; RNA, Messenger; Smad3 Protein; Tetrazolium Salts; Thiazoles; Transforming Growth Factor beta | 2006 |
Inhibition of phosphatidylinositol 3-kinase α (PI3Kα) prevents heterotopic ossification.
Topics: Activin Receptors, Type I; Activins; Animals; Bone Morphogenetic Proteins; Class I Phosphatidylinositol 3-Kinases; Humans; Mice; Ossification, Heterotopic; Phosphoinositide-3 Kinase Inhibitors; Thiazoles | 2019 |